Unknown

Dataset Information

0

Pediatric Drug-Drug Interaction Studies: Barriers and Opportunities.

ABSTRACT:

SUBMITTER: Salerno SN 

PROVIDER: S-EPMC6465091 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Pediatric Drug-Drug Interaction Studies: Barriers and Opportunities.

Salerno Sara N SN   Burckart Gilbert J GJ   Huang Shiew-Mei SM   Gonzalez Daniel D  

Clinical pharmacology and therapeutics 20181025 5

Similar Datasets

Unknown Opportunities and Challenges in Drug Development for Pediatric Cancers.
| S-EPMC7933059 | biostudies-literature
Unknown Labeling Pediatric Products: BPCA Efforts and Orphan Drug Opportunities
| S-EPMC12288554 | biostudies-literature
Unknown Barriers to Adoption of Tailored Drug-Drug Interaction Clinical Decision Support.
| S-EPMC10550365 | biostudies-literature
Unknown Pharmacokinetic Drug Interaction Studies with Enzalutamide.
| S-EPMC4580724 | biostudies-literature
Unknown The epigenome in pediatric acute lymphoblastic leukemia: drug resistance and therapeutic opportunities.
| S-EPMC8992636 | biostudies-literature
Unknown Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology.
| S-EPMC4160817 | biostudies-literature
Unknown Drug-drug interaction studies: regulatory guidance and an industry perspective.
| S-EPMC3691435 | biostudies-literature
Unknown Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies.
| S-EPMC6581936 | biostudies-literature
Unknown Drug-Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies.
| S-EPMC6828636 | biostudies-literature
Unknown When drug treatments bias genetic studies: Mediation and interaction.
| S-EPMC6713387 | biostudies-literature